-
1مورد إلكتروني
المصدر: Division of Cardiology Faculty Papers
مصطلحات الفهرس: Humans, Mitral Valve Insufficiency, Aminobutyrates, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure, Stroke Volume, Angiotensin Receptor Antagonists, Tetrazoles, Ventricular Function, Left, Ventricular Function, Left, Cardiology, Medicine and Health Sciences, article
URL:
https://jdc.jefferson.edu/cardiologyfp/110 https://jdc.jefferson.edu/context/cardiologyfp/article/1111/viewcontent/CIRCULATIONAHA.122.061693.pdf -
2مورد إلكتروني
المصدر: Butt , J H , Dewan , P , Jhund , P S , Anand , I S , Atar , D , Ge , J , Desai , A S , Echeverria , L E , Køber , L , Lam , C S P , Maggioni , A P , Martinez , F , Packer , M , Rouleau , J L , Sim , D , Van Veldhuisen , D J , Vrtovec , B , Zannad , F , Zile , M R , Gong , J , Lefkowitz , M P , Rizkala , A R , Solomon , S D & McMurray , J J V 2022 , ' Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction ' , Journal of the American College of Cardiology , vol. 80 , no. 12 , pp. 1130-1143 .
مصطلحات الفهرس: Aminobutyrates/pharmacology, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Biphenyl Compounds/therapeutic use, Drug Combinations, Frailty, Heart Failure/drug therapy, Humans, Stroke Volume, Tetrazoles/pharmacology, Valsartan, article
URL:
https://curis.ku.dk/portal/da/publications/sacubitrilvalsartan-and-frailty-in-patients-with-heart-failure-and-preserved-ejection-fraction(34894517-1613-415d-9f5a-e00c6f32c7cb).html https://doi.org/10.1016/j.jacc.2022.06.037 https://curis.ku.dk/ws/files/345425679/1_s2.0_S0735109722055966_main.pdf -
3مورد إلكتروني
المصدر: Butt , J H , Dewan , P , Jhund , P S , Anand , I S , Atar , D , Ge , J , Desai , A S , Echeverria , L E , Køber , L , Lam , C S P , Maggioni , A P , Martinez , F , Packer , M , Rouleau , J L , Sim , D , Van Veldhuisen , D J , Vrtovec , B , Zannad , F , Zile , M R , Gong , J , Lefkowitz , M P , Rizkala , A R , Solomon , S D & McMurray , J J V 2022 , ' Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction ' , Journal of the American College of Cardiology , vol. 80 , no. 12 , pp. 1130-1143 .
مصطلحات الفهرس: Aminobutyrates/pharmacology, Angiotensin Receptor Antagonists/pharmacology, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Biphenyl Compounds/therapeutic use, Drug Combinations, Frailty, Heart Failure/drug therapy, Humans, Stroke Volume, Tetrazoles/pharmacology, Valsartan, article
URL:
https://curis.ku.dk/portal/da/publications/sacubitrilvalsartan-and-frailty-in-patients-with-heart-failure-and-preserved-ejection-fraction(34894517-1613-415d-9f5a-e00c6f32c7cb).html https://doi.org/10.1016/j.jacc.2022.06.037 https://curis.ku.dk/ws/files/345425679/1_s2.0_S0735109722055966_main.pdf -
4مورد إلكتروني
مصطلحات الفهرس: Animals, Biphenyl Compounds, Embryo, Nonmammalian, Female, Oryzias, Phosphates, Receptors, Retinoic Acid, Water Pollutants, Chemical, Journal Article, NA
-
5مورد إلكتروني
المصدر: Division of Cardiology Faculty Papers
مصطلحات الفهرس: Humans, Mitral Valve Insufficiency, Aminobutyrates, Valsartan, Biphenyl Compounds, Drug Combinations, Heart Failure, Stroke Volume, Angiotensin Receptor Antagonists, Tetrazoles, Ventricular Function, Left, Ventricular Function, Left, Cardiology, Medicine and Health Sciences, article
URL:
https://jdc.jefferson.edu/cardiologyfp/110 https://jdc.jefferson.edu/context/cardiologyfp/article/1111/viewcontent/CIRCULATIONAHA.122.061693.pdf -
6مورد إلكترونيEffect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion.
المصدر: Cardiovascular drugs and therapy, 18 (3
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Administration, Oral, Angiotensin II Type 1 Receptor Blockers -- administration & dosage, Angiotensin II Type 1 Receptor Blockers -- pharmacology, Angiotensin II Type 1 Receptor Blockers -- therapeutic use, Belgium, Benzimidazoles -- administration & dosage, Benzimidazoles -- pharmacology, Benzimidazoles -- therapeutic use, Biphenyl Compounds -- administration & dosage, Biphenyl Compounds -- pharmacology, Biphenyl Compounds -- therapeutic use, Blood Pressure -- drug effects, Blood Pressure -- physiology, Brachial Artery -- drug effects, Brachial Artery -- physiology, Cold Temperature -- diagnostic use, Coronary Artery Disease -- diagnosis, Coronary Artery Disease -- drug therapy, Coronary Stenosis -- diagnosis, Coronary Stenosis -- drug therapy, Coronary Vessels -- drug effects, Coronary Vessels -- physiopathology, Drug Administration Schedule, Endothelium, Vascular -- drug effects, Endothelium, Vascular -- physiology, Female, Follow-Up Studies, Heart Rate -- drug effects, Heart Rate -- physiology, Humans, Hyperemia -- chemically induced, Individuality, Male, Patient Selection, Pharmacology, Clinical -- methods, Positron-Emission Tomography -- methods, Regional Blood Flow -- drug effects, Regional Blood Flow -- physiology, Tetrazoles -- administration & dosage, Tetrazoles -- pharmacology, Tetrazoles -- therapeutic use, Time Factors, Ultrasonography -- methods, Vasodilation -- drug effects, Vasomotor System -- drug effects, Vasomotor System -- physiology, brachial artery, candesartan, coronary circulation, coronary heart disease, endothelium, regional blood flow, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/51661 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL -
7مورد إلكترونيEffect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion.
المصدر: Cardiovascular drugs and therapy, 18 (3
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Administration, Oral, Angiotensin II Type 1 Receptor Blockers -- administration & dosage, Angiotensin II Type 1 Receptor Blockers -- pharmacology, Angiotensin II Type 1 Receptor Blockers -- therapeutic use, Belgium, Benzimidazoles -- administration & dosage, Benzimidazoles -- pharmacology, Benzimidazoles -- therapeutic use, Biphenyl Compounds -- administration & dosage, Biphenyl Compounds -- pharmacology, Biphenyl Compounds -- therapeutic use, Blood Pressure -- drug effects, Blood Pressure -- physiology, Brachial Artery -- drug effects, Brachial Artery -- physiology, Cold Temperature -- diagnostic use, Coronary Artery Disease -- diagnosis, Coronary Artery Disease -- drug therapy, Coronary Stenosis -- diagnosis, Coronary Stenosis -- drug therapy, Coronary Vessels -- drug effects, Coronary Vessels -- physiopathology, Drug Administration Schedule, Endothelium, Vascular -- drug effects, Endothelium, Vascular -- physiology, Female, Follow-Up Studies, Heart Rate -- drug effects, Heart Rate -- physiology, Humans, Hyperemia -- chemically induced, Individuality, Male, Patient Selection, Pharmacology, Clinical -- methods, Positron-Emission Tomography -- methods, Regional Blood Flow -- drug effects, Regional Blood Flow -- physiology, Tetrazoles -- administration & dosage, Tetrazoles -- pharmacology, Tetrazoles -- therapeutic use, Time Factors, Ultrasonography -- methods, Vasodilation -- drug effects, Vasomotor System -- drug effects, Vasomotor System -- physiology, brachial artery, candesartan, coronary circulation, coronary heart disease, endothelium, regional blood flow, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/51661 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL -
8مورد إلكتروني
المصدر: Investigational new drugs, 16 (1
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adolescent, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols -- adverse effects, Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Biphenyl Compounds -- administration & dosage, Biphenyl Compounds -- adverse effects, Biphenyl Compounds -- pharmacokinetics, Cisplatin -- administration & dosage, Cisplatin -- adverse effects, Cisplatin -- pharmacokinetics, Female, Humans, Male, Middle Aged, Neoplasms -- drug therapy, Neoplasms -- metabolism, Treatment Outcome, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55584 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL -
9مورد إلكتروني
المصدر: Investigational new drugs, 16 (1
مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adolescent, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols -- adverse effects, Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Biphenyl Compounds -- administration & dosage, Biphenyl Compounds -- adverse effects, Biphenyl Compounds -- pharmacokinetics, Cisplatin -- administration & dosage, Cisplatin -- adverse effects, Cisplatin -- pharmacokinetics, Female, Humans, Male, Middle Aged, Neoplasms -- drug therapy, Neoplasms -- metabolism, Treatment Outcome, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55584 http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL -
10مورد إلكتروني
مصطلحات الفهرس: Angioplasty, Transluminal, Percutaneous Coronary, 0 (Biphenyl Compounds), 0 (Heptanoic Acids), 0 (Receptors, Prostaglandin), 0 (Receptors, Thromboxane), 50-78-2 (Aspirin), 57576-52-0 (Thromboxane A2), 85505-64-2 (vapiprost), Aspirin/therapeutic use, Biphenyl Compounds/*therapeutic use, Comparative Study, Constriction, Pathologic/therapy, Coronary Disease/*therapy, Double-Blind Method, Female, Follow-Up Studies, Heptanoic Acids/*therapeutic use, Human, Male, Middle Aged, Receptors, Prostaglandin/drug effects, Receptors, Thromboxane, Recurrence, Support, Non-U.S. Gov't, Thromboxane A2/*antagonists & inhibitors, info:eu-repo/semantics/article